2014 Q1 Form 10-Q Financial Statement
#000156459014001779 Filed on May 05, 2014
Income Statement
Concept | 2014 Q1 | 2013 Q1 |
---|---|---|
Revenue | $3.498M | $2.085M |
YoY Change | 67.77% | -11.28% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $4.230M | $8.800M |
YoY Change | -51.93% | 51.99% |
% of Gross Profit | ||
Research & Development | $13.23M | $14.16M |
YoY Change | -6.59% | 14.18% |
% of Gross Profit | ||
Depreciation & Amortization | $340.0K | $320.0K |
YoY Change | 6.25% | 10.34% |
% of Gross Profit | ||
Operating Expenses | $13.23M | $14.16M |
YoY Change | -6.59% | 14.18% |
Operating Profit | -$13.97M | -$20.88M |
YoY Change | -33.11% | 31.75% |
Interest Expense | $70.00K | $32.00K |
YoY Change | 118.75% | -94.55% |
% of Operating Profit | ||
Other Income/Expense, Net | $62.00K | $14.00K |
YoY Change | 342.86% | -111.48% |
Pretax Income | -$13.84M | -$20.83M |
YoY Change | -33.56% | 26.17% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$13.84M | -$20.83M |
YoY Change | -33.54% | 26.17% |
Net Earnings / Revenue | -395.65% | -998.8% |
Basic Earnings Per Share | ||
Diluted Earnings Per Share | -$526.6K | -$1.139M |
COMMON SHARES | ||
Basic Shares Outstanding | 262.9M | 182.9M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q1 | 2013 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $177.7M | $105.4M |
YoY Change | 68.6% | -1.4% |
Cash & Equivalents | $26.75M | $25.02M |
Short-Term Investments | $150.9M | $80.40M |
Other Short-Term Assets | $2.300M | $1.200M |
YoY Change | 91.67% | -36.84% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $1.700M | $1.547M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $181.7M | $108.1M |
YoY Change | 68.03% | -1.8% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $8.600M | $7.972M |
YoY Change | 7.88% | 14.51% |
Goodwill | $2.400M | |
YoY Change | -3.92% | |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $700.0K | $468.0K |
YoY Change | 49.57% | 6.85% |
Total Long-Term Assets | $11.90M | $11.48M |
YoY Change | 3.62% | 8.83% |
TOTAL ASSETS | ||
Total Short-Term Assets | $181.7M | $108.1M |
Total Long-Term Assets | $11.90M | $11.48M |
Total Assets | $193.6M | $119.6M |
YoY Change | 61.84% | -0.87% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.900M | $1.727M |
YoY Change | 10.02% | -26.76% |
Accrued Expenses | $6.600M | $8.166M |
YoY Change | -19.18% | 29.6% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $16.00M | $17.06M |
YoY Change | -6.21% | -33.92% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $3.800M | $621.0K |
YoY Change | 511.92% | -1.58% |
Total Long-Term Liabilities | $3.800M | $621.0K |
YoY Change | 511.92% | -1.58% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $16.00M | $17.06M |
Total Long-Term Liabilities | $3.800M | $621.0K |
Total Liabilities | $19.70M | $21.69M |
YoY Change | -9.19% | -17.97% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$516.1M | -$456.3M |
YoY Change | 13.09% | 19.44% |
Common Stock | $263.0K | $183.0K |
YoY Change | 43.72% | 16.56% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $173.9M | $97.93M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $193.6M | $119.6M |
YoY Change | 61.83% | -0.87% |
Cashflow Statement
Concept | 2014 Q1 | 2013 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$13.84M | -$20.83M |
YoY Change | -33.54% | 26.17% |
Depreciation, Depletion And Amortization | $340.0K | $320.0K |
YoY Change | 6.25% | 10.34% |
Cash From Operating Activities | -$11.18M | -$18.89M |
YoY Change | -40.8% | 130.85% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $398.0K | $535.0K |
YoY Change | -25.61% | -42.6% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $15.13M | $36.89M |
YoY Change | -58.99% | -781.89% |
Cash From Investing Activities | $14.73M | $36.35M |
YoY Change | -59.48% | -673.09% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 70.00K | 15.00K |
YoY Change | 366.67% | -99.33% |
NET CHANGE | ||
Cash From Operating Activities | -11.18M | -18.89M |
Cash From Investing Activities | 14.73M | 36.35M |
Cash From Financing Activities | 70.00K | 15.00K |
Net Change In Cash | 3.620M | 17.48M |
YoY Change | -79.29% | -242.45% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$11.18M | -$18.89M |
Capital Expenditures | $398.0K | $535.0K |
Free Cash Flow | -$11.58M | -$19.42M |
YoY Change | -40.38% | 113.11% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
1125000 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
186294000 | |
CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-148000 | |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-502211000 | |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
204622000 | |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
263000 | |
CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
263000 | |
CY2014Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
689729000 | |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
688390000 | |
CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-88000 | |
CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-516051000 | |
CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
173853000 | |
CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
193585000 | |
CY2014Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2014Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2014Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2014Q1 | us-gaap |
Contracts Revenue
ContractsRevenue
|
2373000 | |
CY2013Q1 | us-gaap |
Contracts Revenue
ContractsRevenue
|
883000 | |
CY2013Q1 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
760000 | |
CY2014Q1 | dvax |
Unoccupied Facility Expense
UnoccupiedFacilityExpense
|
77000 | |
CY2014Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
17465000 | |
CY2013Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
22964000 | |
CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
32000 | |
CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13840000 | |
CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20825000 | |
CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.11 | |
CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
262826000 | |
CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
182847000 | |
CY2013Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14164000 | |
CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
262856000 | |
CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | |
CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
262856000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
262796000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
262796000 | |
CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20879000 | |
CY2013Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
72000 | |
CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13231000 | |
CY2014Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
65000 | |
CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
62000 | |
CY2013Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
14000 | |
CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13967000 | |
CY2014Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4157000 | |
CY2013Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8800000 | |
CY2014Q1 | us-gaap |
Revenues
Revenues
|
3498000 | |
CY2013Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
400000 | |
CY2013Q4 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
600000 | |
CY2014Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
69000 | |
CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-8000 | |
CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-9000 | |
CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-347000 | |
CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
60000 | |
CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-355000 | |
CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-13780000 | |
CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-21180000 | |
CY2014Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
339000 | |
CY2013Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
319000 | |
CY2014Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
20000 | |
CY2014Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-264000 | |
CY2013Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-280000 | |
CY2014Q1 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
77000 | |
CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1270000 | |
CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4266000 | |
CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
103000 | |
CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
542000 | |
CY2014Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
948000 | |
CY2013Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-835000 | |
CY2014Q1 | dvax |
Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
|
-266000 | |
CY2013Q1 | dvax |
Increase Decrease In Restricted Cash And Other Assets For Operating Activities
IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities
|
-13000 | |
CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
154000 | |
CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-439000 | |
CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1671000 | |
CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-1905000 | |
CY2014Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
3036000 | |
CY2013Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-888000 | |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-11176000 | |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-18886000 | |
CY2014Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
13819000 | |
CY2013Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
13454000 | |
CY2014Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
28949000 | |
CY2013Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
50340000 | |
CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
398000 | |
CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
535000 | |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
14732000 | |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
36351000 | |
CY2013Q1 | dvax |
Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
|
-142000 | |
CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
10000 | |
CY2014Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
69000 | |
CY2013Q1 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
147000 | |
CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
69000 | |
CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
15000 | |
CY2014Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
3000 | |
CY2013Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-63000 | |
CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
3628000 | |
CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
17417000 | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7599000 | |
CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
25016000 | |
CY2014Q1 | dvax |
Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
|
274000 | |
CY2013Q1 | dvax |
Supplemental Disposal Of Assets
SupplementalDisposalOfAssets
|
1000 | |
CY2014Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-69000 | |
CY2013Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
8000 | |
CY2014Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> requires management to make informed estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates and assumptions.</font></p></div> | |
CY2013Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
189407000 | |
CY2014Q1 | dvax |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
47000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
2332000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
2382000 | |
CY2014Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2014Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
177700000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
177641000 | |
CY2013Q4 | dvax |
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
|
16000 | |
CY2014Q1 | dvax |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
9000 | |
CY2013Q4 | dvax |
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
|
47000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
177679000 | |
CY2013Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
189376000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
86050000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
64841000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
|
150891000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
86070000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
64859000 | |
CY2014Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
150929000 | |
CY2014Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
400000 | |
CY2014Q1 | us-gaap |
Deferred Rent Credit
DeferredRentCredit
|
600000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
1679000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
2282000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
1350000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
2496000 | |
CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
12521000 | |
CY2014Q1 | us-gaap |
Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
|
38400000 | |
CY2011 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
12000000 | |
CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
77800000 | |
CY2013Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
30800000 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
15765000 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
4890000 | |
CY2014Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
||
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
20105000 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
20105000 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
10899000 | |
CY2013Q4 | dvax |
Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
|
3.17 | |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y9M4D | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1566000 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
1566000 | |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
969000 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.71 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2014Q1 | dvax |
Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
|
2.80 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
2.80 | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.32 | |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y3M | |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P6Y3M | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P4Y | |
CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2100000 | |
CY2014Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
400000 | |
CY2013Q1 | dvax |
Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
|
0 |